Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ADC rapeutics

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

Here's a roundup of top developments in the biotech space over the last 24 hours:

Analyst Ratings for ADC Therapeutics

Analysts have provided the following ratings for ADC Therapeutics (NYSE:ADCT) within the last quarter:

RBC Capital Maintains Outperform Rating for ADC Therapeutics: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of ADC Therapeutics (NYSE:ADCT) and lower its price target from $34.00 to $30.00. Shares of ADC Therapeutics are trading down 1.34% over the last 24 hours, at $7.71 per share.

Earnings Outlook For ADC Therapeutics

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that ADC Therapeutics will report an earnings per share (EPS) of $-0.70.

inkl

Read news from The Economist, FT, and more,
with one subscription

How To Attend ADC Therapeutics Q1 2022 Earnings Conference Call

How To Attend ADC Therapeutics Q1 2022 Earnings Conference Call

ADC Therapeutics (NYSE:ADCT) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend ADC Therapeutics (ADCT) Conference Call Follow this link to access the live webcast.

Earnings Preview For ADC Therapeutics

Earnings Preview For ADC Therapeutics

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate that ADC Therapeutics will report an earnings per share (EPS) of $-0.86.

Organisations

Berkshire Hathaway

Western Digital

Micron Technology

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play